New optimized vaccine approach targets Hepatitis C virus variability
A method to design vaccines for highly variable viruses like the hepatitis C virus.
Source: news-medical.net
Stay updated with breaking news from Analysis Resource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A method to design vaccines for highly variable viruses like the hepatitis C virus.
Researchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers.
The National Cancer Institute (NCI) of the National Institutes of Health has granted over $4.2 million to launch the Cancer Epitope Database and Analysis Resource (CEDAR), led by La Jolla Institute for Immunology (LJI) Professors Alessandro Sette, Dr. Biol. Sci., and Bjoern Peters, Ph.D.